Skip to main content

Table 4 Comparison of secondary outcomes between study & control groups

From: The long-term neurodevelopmental outcomes of toddlers with SARS-CoV-2 infection in the neonatal period: a prospective observational study

 

Study Group

SARS-CoV-2 (+)

(n = 30)

Control Group

SARS-CoV-2 (-)

(n = 60)

P

Head circumference at birth (cm) mean ± SDS

34.98 ± 0.77

35.06 ± 0.82

0.64

Head circumference 1st month (cm) mean ± SDS

37.98 ± 0.77

38.00 ± 0.90

0.64

Head circumference 6th month (cm) mean ± SDS

43.76 ± 1.15

43.73 ± 1.14

0.89

Head circumference 12th month (cm) mean ± SDS

45.90 ± 0.79

46.63 ± 1.06

< 0.001

Head circumference 18th month (cm) mean ± SDS

47.76 ± 0.74

47.83 ± 1.01

0.72

Head circumference, 24th month (cm) mean ± SDS

49.56 ± 0.78

49.45 ± 0.82

0.70

Breastmilk intake time (/days) mean ± SDS

3.76 ± 1.38

5.31 ± 2.60

0.05

Hospitalization time (/days) mean ± SDS

10.73 ± 3.59

6.71 ± 3.58

< 0.001